Ionova enters clinical trial partnership with Merck to evaluate INV-1120 in combo with Keytrudain patients with advanced solid tumours

Ionova Life Science Co., Ltd., a clinical-stage biotech company, announces it has entered into a clinical trial collaboration agreement with MSD (Merck & Co., Inc., Kenilworth, NJ., USA) to evaluate clinical benefits of INV-1120, Ionova’s EP4...

India's Pharma exports witnessed growth up to 103% since 2013-14

Indian pharma exports witnessed a growth of 103 per cent since 2013-14. A significant rise has been reported from Rs 90,415 crores in 2013-14 to Rs 1,83,422 crores in 2021-22, the Ministry of Commerce and Industry informed...

Sputnik Light to be specified as precaution dose for those vaccinated with Sputnik V

The National Technical Advisory Group on Immunisation (NTAGI) recommended that the Russian COVID-19 vaccine Sputnik Light which contains the same ingredients as the first dose of Sputnik V can be taken as a precaution dose, said Sources...

Advantages of Adopting Cloud Computing in Pharma Industry

According to a recent report published by Research Reports World, the revenue of Cloud Computing in Pharma Industry was $3173 million in 2019 and will reach $7021 million in 2025 at a CAGR of 14.15 per cent during 2020-2025.

NTAGI panel acclaims inclusion of Covovax in vaccination drive for 12-17 age group

The Standing Technical Sub-Committee of the NTAGI has recommended inclusion of the Serum Institute's Covovax in the national COVID-19 vaccination programme for children aged 12 to 17 years, sources said on Friday.

Big Data : The Silver Bullet for Drug Discovery

The Indian pharmaceutical segment holds an important position in the global pharmaceutical industry.

FDA approves Bristol Myers' oral heart disease drug Mavacamten

Bristol Myers Squibb said on Thursday the U.S. Food and Drug Administration (FDA) approved its oral heart disease drug Mavacamten, making it the first cardiac myosin inhibitor to be permitted for use in the country.

ManipalCigna Health Insurance launches ProHealth Prime a absolute healthcare plan for better coverage and care

ManipalCigna Health Insurance has launched the ProHealth Prime’ plan. The new plan not only covers all types of hospitalization expenses but also comes with innovative features such Cashless OPD coverage for doctor consultation..

Alterity Therapeutics receives UK MHRA nod to continue phase 2 trial of ATH434 to treat multiple system atrophy

Alterity Therapeutics, a clinical stage biotechnology company, announced that the United Kingdom Medicines & Healthcare products Regulatory Agency (MHRA) has accepted Alterity’s clinical trial authorization (CTA) request to conduct its phase 2...

Lupin and Yabao declare Strategic Partnership in China

Global pharma major Lupin Limited (Lupin) today announced that it has entered into a strategic partnership with Yabao Pharmaceutical Co. Inc. (Yabao), to meet the growing demand for quality drugs with pediatric formulations in the Chinese markets...

© 2025 India Pharma Outlook. All Rights Reserved.